DILH
TXMD icon

Dai-ichi Life Holdings’s TherapeuticsMD TXMD Stock Holding History

Dai-ichi Life Holdings’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,590
Closed -$882K – 419
2016
Q3 		$882K Buy
+2,590
New +$946K 0.03% 417

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dai-ichi Life Holdings's TXMD Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of TherapeuticsMD (TXMD) in Q4 2016, closing a stake of 2,590 shares — an estimated $882K sold.

Dai-ichi Life Holdings first reported a position in TXMD in Q3 2016 and held it in 1 quarter. The position peaked at $882K in Q3 2016. 146 funds tracked by Wall St. Rank hold TXMD as of Q4 2016.

  • Dai-ichi Life Holdings reported no remaining TherapeuticsMD position as of Q4 2016 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 2,590 TherapeuticsMD shares in Q4 2016, an estimated $882K.
  • Dai-ichi Life Holdings first reported a position in TherapeuticsMD in Q3 2016 and held it in 1 quarter.
  • Dai-ichi Life Holdings's TherapeuticsMD position peaked at $882K in Q3 2016.
  • 146 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.